We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
-12.48%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.02B
AUM Growth
-$171M
(-14%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
366
New
66
Increased
95
Reduced
44
Closed
95
Avg Time Held
1.5
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.24M |
| 2 |
Henry Schein
HSIC
|
+$1.58M |
| 3 |
Vanguard Health Care ETF
VHT
|
+$949K |
| 4 |
W.R. Berkley
WRB
|
+$724K |
| 5 |
Aramark
ARMK
|
+$656K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$2.27M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1M |
| 3 |
Honeywell
HON
|
+$865K |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$787K |
| 5 |
Ansys
ANSS
|
+$629K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.02% |
| 2 | Industrials | 17.59% |
| 3 | Financials | 11.84% |
| 4 | Communication Services | 11.54% |
| 5 | Healthcare | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
UMPQ
101
DELISTED
Umpqua Holdings Corp
UMPQ
| $826K | 0.08% |
51,966
+6,469
| +14% | +$122K |
2016 Q1
11 quarters
|
|
102
Factset
FDS
$10.7B
| $803K | 0.08% |
4,011
-1,686
| -30% | -$371K |
2016 Q1
11 quarters
|
|
103
Johnson & Johnson
JNJ
$616B
| $801K | 0.08% |
6,207
-620
| -9% | -$86.5K |
2017 Q3
5 quarters
|
|
104
Prosperity Bancshares
PB
$8.15B
| $791K | 0.08% |
12,703
+7,471
| +143% | +$493K |
2018 Q3
1 quarter
|
|
105
Bio-Techne
TECH
$11.4B
| $791K | 0.08% |
21,868
-10,312
| -32% | -$431K |
2016 Q1
11 quarters
|
|
106
Choice Hotels
CHH
$4.88B
| $776K | 0.08% |
10,846
+6,047
| +126% | +$454K |
2018 Q3
1 quarter
|
|
107
Novartis
NVS
$286B
| $760K | 0.07% |
9,889
+3,213
| +48% | +$250K |
2016 Q1
11 quarters
|
|
108
Merck
MRK
$360B
| $750K | 0.07% |
10,289
+23
| +0.2% | +$1.62K |
2016 Q1
11 quarters
|
|
109
Texas Instruments
TXN
$252B
| $739K | 0.07% |
7,816
+122
| +2% | +$11.8K |
2017 Q3
5 quarters
|
|
110
Morningstar
MORN
$7.78B
| $728K | 0.07% |
6,628
-4,139
| -38% | -$485K |
2016 Q1
11 quarters
|
|
|
RDS.A
111
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $726K | 0.07% |
12,463
-2,343
| -16% | -$145K |
2016 Q1
11 quarters
|
|
112
Sensient Technologies
SXT
$5.69B
| $719K | 0.07% |
12,874
+7,570
| +143% | +$495K |
2018 Q3
1 quarter
|
|
113
Graco
GGG
$13.3B
| $711K | 0.07% |
16,996
-3,283
| -16% | -$137K |
2016 Q1
11 quarters
|
|
114
Canadian National Railway
CNI
$73.6B
| $673K | 0.07% |
9,083
+2,927
| +48% | +$243K |
2016 Q1
11 quarters
|
|
115
Broadcom
AVGO
$1.57T
| $660K | 0.06% |
+25,960
| New | +$613K |
2018 Q4
0 quarters
|
|
116
AB InBev
BUD
$163B
| $656K | 0.06% |
9,969
+6,147
| +161% | +$470K |
2016 Q1
11 quarters
|
|
117
DELISTED
Unilever NV New York Registry Shares
UN
| $650K | 0.06% |
12,074
+6,393
| +113% | +$349K |
2016 Q1
11 quarters
|
|
118
Credicorp
BAP
$31B
| $634K | 0.06% |
2,858
| – | – |
2016 Q1
11 quarters
|
|
|
VAR
119
DELISTED
Varian Medical Systems, Inc.
VAR
| $622K | 0.06% |
5,493
| – | – |
2016 Q1
11 quarters
|
|
120
Trimble
TRMB
$13.9B
| $620K | 0.06% |
18,837
-7,158
| -28% | -$263K |
2016 Q4
8 quarters
|
|
121
Invesco QQQ Trust
QQQ
$475B
| $617K | 0.06% |
4,000
| – | – |
2016 Q1
11 quarters
|
|
122
Westamerica Bancorp
WABC
$1.42B
| $598K | 0.06% |
10,746
+68
| +0.6% | +$4K |
2016 Q1
11 quarters
|
|
123
BHP
BHP
$212B
| $593K | 0.06% |
13,760
| – | – |
2016 Q1
11 quarters
|
|
124
PPG Industries
PPG
$23.9B
| $573K | 0.06% |
5,609
+26
| +0.5% | +$2.69K |
2017 Q3
5 quarters
|
|
|
ABB
125
DELISTED
ABB Ltd
ABB
| $562K | 0.06% |
29,574
+17,644
| +148% | +$357K |
2017 Q4
4 quarters
|
|
Similar funds
Henshaw Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Henshaw Capital held 366 positions worth $1.02B, down 14% from $1.19B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Henshaw Capital's Q4 2018 filing shows 66 new, 95 increased, 44 reduced and 95 closed positions. Its largest new stake was Vanguard Health Care ETF: 5,600 shares worth $899K. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $2.27M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Financials.
- Henshaw Capital's largest Q4 2018 buy was Vanguard Health Care ETF: 5,600 shares worth $899K.
- Henshaw Capital added most to CVS Health in Q4 2018, an estimated $2.24M increase.
- Henshaw Capital's biggest Q4 2018 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $1M.
- Henshaw Capital fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $2.27M.
- Henshaw Capital's ten largest holdings make up 34% of its $1.02B portfolio in Q4 2018.
- Henshaw Capital opened 66 new positions and closed 95 in Q4 2018.
- Henshaw Capital's portfolio value fell 14% quarter-over-quarter to $1.02B.
Based on Henshaw Capital's 13F filing for Q4 2018, filed 28 May 2026.